Not applicableStudy completedNCT03098589What this trial is testingRevlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)Who this might be right forLymphoma Celgene 1,149
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714What this trial is testingErdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more National Cancer Institute (NCI) 20
Post-approval studies (Phase 4)Study completedNCT00277160What this trial is testingPrimary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With CancerWho this might be right forNeutropeniaBreast CancerLung Cancer+2 more Amgen 852
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more National Cancer Institute (NCI) 1,377
Not applicableEnded earlyNCT00965861What this trial is testingSCRI Tissue Testing RegistryWho this might be right forMelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652What this trial is testingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more National Cancer Institute (NCI) 13
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Large-scale testing (Phase 3)Study completedNCT00014391What this trial is testingRibavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Not applicableUnknownNCT06081270What this trial is testingProspective Study on Resistance-associated Mutations in Metastatic Lung CancerWho this might be right forLung Cancer University of Milano Bicocca 20
Not applicableLooking for participantsNCT03702309What this trial is testingLiquid Biopsy Evaluation and Repository Development at Princess MargaretWho this might be right forCancerBreast CancerLung Cancer+15 more University Health Network, Toronto 2,500
Large-scale testing (Phase 3)Study completedNCT03194893What this trial is testingA Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive CancerWho this might be right forNeoplasms Hoffmann-La Roche 50
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69
Early research (Phase 1)Ended earlyNCT04187872What this trial is testingLITT and Pembrolizumab in Recurrent Brain MetastasisWho this might be right forMelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more University of Florida 10
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Testing effectiveness (Phase 2)Ended earlyNCT02711137What this trial is testingOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesWho this might be right forSolid Tumors Incyte Corporation 137
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329